Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Piperidine | HCID 8082 | — |
| Reactant | HCID 178423760 | HCID 178423760 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 178423761 | HCID 178423761 | — |
Reaction Steps
Compound (15a) is treated with 20-50% piperidine in N,N-dimethylformamide (0.1 M) to remove the Fmoc protecting group. The residue is purified by reverse phase chromatography (acetonitrile/water with 0.05% trifluoroacetic acid) and then dissolved in 95% trifluoroacetic acid-methylene chloride (0.1 M). The mixture is stirred at 25° C. for 6 h and then concentrated under reduced pressure. The residue is purified by reverse phase chromatography (acetonitrile/water with 0.05% trifluoroacetic acid) to provide the title compound.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09044464B2 |
|---|
| Source dataset | uspto-grants-2015_06 |
|---|
| ORD ID | ord-a18da48203c34bd39d301fa12ad72b25 |
|---|
| Source note | uspto-grants-2015_06 |
|---|